Clincosm LogoSign in Get a demo

hodgkin lymphoma

Showing 1 - 25 of 190
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

Not yet recruiting
  • Hodgkin Lymphoma
  • Tislelizumab, AVD, Radiotherapy
  • (no location specified)
Nov 15, 2022

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma Trial in Winston-Salem, Richmond (other, diagnostic test,

Not yet recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Exercise with Trainerize application
  • +5 more
  • Winston-Salem, North Carolina
  • +1 more
Oct 27, 2022

Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Brentuximab Vedotin 50 MG [Adcetris]
  • Leon, Guanajuato, Mexico
    Hospital Regional Alta Especialidad Bajio
Oct 24, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial (IMT-009)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • (no location specified)
Sep 29, 2022

ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

Not yet recruiting
  • ALL
  • +3 more
  • Transcranial photobiomodulation (tPBM) - Mobile System
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 21, 2022

Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • brentuximab vedotin
  • (no location specified)
Aug 18, 2022

Hodgkin Lymphoma Trial in Worldwide (Doxorubicin, Bleomycin, Vinblastine)

Completed
  • Hodgkin Lymphoma
  • Antwerpen, Belgium
  • +64 more
Aug 18, 2022

Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

Not yet recruiting
  • Hodgkin Lymphoma
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Aug 18, 2022

Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 15, 2022

Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • gemcitabine, cisplatin and tislelizumab
  • Brussels, Belgium
  • +14 more
Aug 12, 2022

Hodgkin Lymphoma Trial in Guadalajara (Pentoxifylline, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Aug 4, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Not yet recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 2, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • (no location specified)
Jul 28, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Jul 15, 2022

Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))

Recruiting
  • Multiple Myeloma
  • +13 more
  • RITA (App)
  • Milano, Italy
    ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022

A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Recruiting
  • Hodgkin Lymphoma
  • No Intervention
  • Wroclaw, Dolnoslskie, Poland
  • +14 more
Jun 23, 2022

Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

Recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Stanford, California
    Stanford University
Jun 21, 2022

Blood Clots and Bleeding in Hematological Malignancies, HAT

Recruiting
  • Acute Leukemia
  • +7 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jun 17, 2022

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

Recruiting
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • DOC Group B
  • +16 more
  • Valhalla, New York
    New York Medical College
Jun 9, 2022

Hodgkin Lymphoma Trial (pembrolizumab)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • (no location specified)
May 30, 2022

Circulating Tumor DNA Genotyping for Biological Monitoring of

Active, not recruiting
  • Hodgkin Lymphoma
    • Avellino, Italy
    • +12 more
    May 26, 2022

    Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

    Recruiting
    • Hodgkin Lymphoma
    • Involved site radiotherapy
    • +6 more
    • Aberdeen, United Kingdom
    • +6 more
    May 24, 2022